Janis Curtis, MSPH, MA, associate director of the Duke Clinical Data Research Networks (CDRN) Program, has been named a 2023 Changemaker in Health for her courage, curiosity, and determination to help transform the global health ecosystem through the best use of information technology.

Andrea Deyrup, MD, PhD, a professor in the Department of Pathology, challenges a long history of race-based medicine that she says is often based on questionable assumptions and flawed science yet deeply embedded in clinical decision-making.

Learn the stories of places and things named in honor of Black students, faculty and staff

On January 27, 2023,  the Food and Drug Administration approved a new targeted therapy for hard-to-treat advanced breast cancers. Its development was made possible by research and advocacy from the lab of Donald McDonnell, PhD, in the Department of Pharmacology and Cancer Biology. 

Through her research and administrative work, Sherilynn Black has developed expertise in what scholars need to thrive in academic careers. Recognized as a national leader, she will guide a new initiative at the National Academies of Sciences, Engineering and Medicine on mentorship, professional development and well-being.

Popular TikTok videos that highlight ways to obtain a medication abortion are typically informative and useful, according to a study led by Duke Health researchers.

Production will enable human studies to determine whether the vaccine protects against a wide variety of coronaviruses, including those that cause COVID-19 

Pathogenic fungi (Candida, Aspergillus, Cryptococcus and others) are notorious killers of immune-compromised people. But for the most part, healthy people have not had to worry about them, and the vast majority of the planet’s potentially pathogenic fungi don’t do well in the heat of our bodies. But all that may be about to change.

A 10-year partnership between the Department of Pathology and Duke Cancer Institute has helped researchers make advances in human tissue-based research and cancer precision medicine.

Two members of the Duke University School of Medicine faculty have been elected as 2022 fellows by the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.